Gene expression analysis of cell death induction by Taurolidine in different malignant cell lines

被引:12
作者
Chromik, Ansgar M. [1 ]
Hahn, Stephan A. [2 ]
Daigeler, Adrien [3 ]
Flier, Annegret [1 ]
Bulut, Daniel [4 ]
May, Christina [1 ]
Harati, Kamran [1 ]
Roschinsky, Jan [1 ]
Suelberg, Dominique [1 ]
Weyhe, Dirk [1 ]
Mittelkoetter, Ulrich [1 ]
Uhl, Waldemar [1 ]
机构
[1] Ruhr Univ Bochum, Dept Visceral & Gen Surg, St Josef Hosp, D-44791 Bochum, Germany
[2] Ruhr Univ Bochum, Dept Mol Gastrointestinal Oncol, D-44780 Bochum, Germany
[3] BG Unfallkrankenhaus, Dept Hand Plast & Reconstruct Surg, Burn Ctr, D-67071 Ludwigshafen, Germany
[4] Ruhr Univ Bochum, Dept Med 1, St Josef Hosp, D-44791 Bochum, Germany
关键词
ACTIVATING TRANSCRIPTION FACTOR-3; SUPPRESSIVE REAGENT TAUROLIDINE; ANTINEOPLASTIC AGENT; BCL-2; FAMILY; IN-VITRO; GROWTH; STRESS; APOPTOSIS; PROTEINS; MODEL;
D O I
10.1186/1471-2407-10-595
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: The anti-infective agent Taurolidine (TRD) has been shown to have cell death inducing properties, but the mechanism of its action is largely unknown. The aim of this study was to identify potential common target genes modulated at the transcriptional level following TRD treatment in tumour cell lines originating from different cancer types. Methods: Five different malignant cell lines (HT29, Chang Liver, HT1080, AsPC-1 and BxPC-3) were incubated with TRD (100 mu M, 250 mu M and 1000 mu M). Proliferation after 8 h and cell viability after 24 h were analyzed by BrdU assay and FACS analysis, respectively. Gene expression analyses were carried out using the Agilent -microarray platform to indentify genes which displayed conjoint regulation following the addition of TRD in all cell lines. Candidate genes were subjected to Ingenuity Pathways Analysis and selected genes were validated by qRT-PCR and Western Blot. Results: TRD 250 mu M caused a significant inhibition of proliferation as well as apoptotic cell death in all cell lines. Among cell death associated genes with the strongest regulation in gene expression, we identified pro-apoptotic transcription factors (EGR1, ATF3) as well as genes involved in the ER stress response (PPP1R15A), in ubiquitination (TRAF6) and mitochondrial apoptotic pathways (PMAIP1). Conclusions: This is the first conjoint analysis of potential target genes of TRD which was performed simultaneously in different malignant cell lines. The results indicate that TRD might be involved in different signal transduction pathways leading to apoptosis.
引用
收藏
页数:13
相关论文
共 62 条
[1]
Taurolidine and oxidative stress: a rationale for local treatment of mesothelioma [J].
Aceto, N. ;
Bertino, P. ;
Barbone, D. ;
Tassi, G. ;
Manzo, L. ;
Porta, C. ;
Mutti, L. ;
Gaudino, G. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (06) :1399-1407
[2]
Adler HT, 1999, MOL CELL BIOL, V19, P7050
[3]
The roles of ATF3 in glucose homeostasis - A transgenic mouse model with liver dysfunction and defects in endocrine pancreas [J].
Allen-Jennings, AE ;
Hartman, MG ;
Kociba, GJ ;
Hai, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :29507-29514
[4]
Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein [J].
Baek, SJ ;
Kim, JS ;
Moore, SM ;
Lee, SH ;
Martinez, J ;
Eling, TE .
MOLECULAR PHARMACOLOGY, 2005, 67 (02) :356-364
[5]
Troglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) ligand, selectively induces the early growth response-1 gene independently of PPARγ -: A novel mechanism for its anti-tumorigenic activity [J].
Baek, SJ ;
Wilson, LC ;
Hsi, LC ;
Eling, TE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) :5845-5853
[6]
TAUROLIDINE PERITONEAL-LAVAGE AS PROPHYLAXIS AGAINST INFECTION AFTER ELECTIVE COLORECTAL SURGERY [J].
BAKER, DM ;
JONES, JA ;
NGUYENVANTAM, JS ;
LLOYD, JH ;
MORRIS, DL ;
BOURKE, JB ;
STEELE, RJC ;
HARDCASTLE, JD .
BRITISH JOURNAL OF SURGERY, 1994, 81 (07) :1054-1056
[7]
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin [J].
Baron, V ;
Adamson, ED ;
Calogero, A ;
Ragona, G ;
Mercola, D .
CANCER GENE THERAPY, 2006, 13 (02) :115-124
[8]
Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats [J].
Braumann, C ;
Schoenbeck, M ;
Menenakos, C ;
Kilian, M ;
Jacobi, CA .
CLINICAL & EXPERIMENTAL METASTASIS, 2005, 22 (01) :77-83
[9]
The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis [J].
Braumann, C ;
Henke, W ;
Jacobi, CA ;
Dubiel, W .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (02) :225-230
[10]
The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma - a mouse model [J].
Braumann, Chris ;
Jacobi, Christoph A. ;
Rogalla, Stephan ;
Menenakos, Charalambos ;
Fuehrer, Kirsten ;
Trefzer, Uwe ;
Hofmann, Maja .
JOURNAL OF SURGICAL RESEARCH, 2007, 143 (02) :372-378